Last reviewed · How we verify

NCT06239038

Does Electrocautery Increase Postoperative Pain in Primary Total Knee Arthroplasty

Status unknown Phase 3 Last updated 6 February 2024
What this trial tests

Phase 3 trial testing total knee arthroplasty in Osteoarthritis, Knee in 132 participants. Status unknown.

Timeline
11 October 2021
Primary endpoint
31 December 2023
29 February 2024

Quick facts

Lead sponsorPolice General Hospital, Thailand
PhasePhase 3
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment132
Start date11 October 2021
Primary completion31 December 2023
Estimated completion29 February 2024
Sites1 location across Thailand

Drugs / interventions tested

Conditions studied

Sponsor

Police General Hospital, Thailand

Who can join

58 and older, any sex, with Osteoarthritis, Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Total knee arthroplasty (TKA) is a successful treatment for end-stage osteoarthritis of the knee. The main advantages of TKA are to relieve the pain of the knee, improve the knee function, restore lower limb alignment, and improve the quality of life for patients. During TKA, some surgeons prefer using a scalpel while others using electrocautery to expose the articular cavity. Whether the use of scalpel can lead to better and faster recovery after the primary TKA is still controversial. The aim of this study was to compare the clinical outcomes of using the scalpel and the electrocautery in primary TKA

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of total knee arthroplasty

Trials testing the same drug.

Other recruiting trials for Osteoarthritis, Knee

Currently open trials in the same condition.

Other Police General Hospital, Thailand trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06239038.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing